Have a listen to our podcast about the risk of cardiovascular disease with ADT in prostate cancer #APCCC24 Thomas Suter and Chuck Ryan are quizzed about it’s relevance and which tests are needed. podcasters.spotify.com/pod/show/the-u…

Check out our APCCC podcasts with Jason Efstathiou and Piet Ost discuss the data for and against adjuvant radiotherapy. podcasters.spotify.com/pod/show/the-u…

APCCC debate with Thomas Zilli and Pierre Blanchard covering radiation therapy for metastatic disease from Lugano. Thanks to Neeraj Agarwal, MD, FASCO for help with the tweet. #APCCC2024 OncoAlert . t.ly/D7N0_

Somethings a Brewin here in Lugano🇨🇭
Live from #APCCC24
Uromigos GU Cast | Urology podcast! OncoAlert 🚨
WEBCAST...Coming Soon‼️

Declan Murphy 🇦🇺
Renu Eapen 🇦🇺
Brian Rini, MD 🇺🇸
Tom Powles 🇬🇧
Gil Morgan, MD 🇺🇸

Sumanta K. Pal, MD, FASCO Cristiane D Bergerot Daniel Heng Andrea Apolo, M.D. Toni Choueiri, MD Petros Grivas…

⁦Tom Powles⁩ and I are at the amazing APCCC prostate meeting. Stay tuned for some special podcasts from Lugano!!

Congratulations to the team including Nizar MD Anderson Cancer Center Brian Rini, MD on first #siRNA #RCC phase 1 bit.ly/AROHIF2trial with ArrowheadPharma #HIF2 siRNA building upon bit.ly/siHIF2RCCpre (PMID36190432) opening new field.

Everything you wanted to know about thr POUT trial but were after to ask Brian Rini, MD 💙alison birtle Tom Powles podcasters.spotify.com/pod/show/the-u…

. 💯 agree Daniel Goldstein MD & Tom Powles. Flat dose IO makes me 🫨 too. ~30% overdosage? Discussed this w/our team. Argument was flat dose ⬇️ errors w/o ⬆️ tox. I am not sure.
Eg AVE 800mg vs 10mg/kg. How many pts with mUC weigh 80kg?
FYI Ricky Frazer
podcasts.apple.com/gb/podcast/the…

Congrats to Team L.A. Sumanta K. Pal, MD, FASCO Tanya Dorff and Petros Grivas for the inaugural #UromigosCup ! Enjoy your time with the Cup. Send pictures we miss it. 😢

🎧 Catch the latest episode of the Uromigos (@brian_rini, Tom Powles) with Daniel Goldstein MD on dosing issues and dosing changes in drugs such as #nivolumab and #pembrolizumab , as well as other immune checkpoint inhibitors.

👂 Listen Here: buff.ly/3W7fDcG

An excellent, balanced discussion of adjuvant therapy in RCC from Brian Rini, MD Tom Powles Uromigos . An area of consensus - we need better ways to risk stratification risk of recurrence, including biomarkers #IKCSEU24 Kidney Cancer

🎙️ Brian Rini, MD and Tom Powles of the Uromigos spoke with Matt Galsky about the #OS signal data from #CheckMate274 , which analyzed the use of #adjuvant #nivolumab in patients with #MIBC .

👂 Listen Here: buff.ly/3JioJM6

👀 Don't miss our latest video with Katy Beckermann and Michael Atkins, MD, of Georgetown Lombardi, where they discuss LAG-3 With PD-1 in #KidneyCancer .

📺 Watch Now: buff.ly/3U9ypi9

Adjuvant nivo #EAU24 Matt Galsky podcasters.spotify.com/pod/show/the-u…

An exceptional Uromigos 2-part podcast on CM274 OS data presented by Matt Galsky & IMvigor010 ctDNA neg pts outcomes by Tom Powles
Scintillating discussion on biomarkers, ongoing trials (IMvigor011 & MODERN) & more! Must listen!
Brian Rini, MD

Check out the AKCI didactic video YouTube page for the latest lecture by Boyi Gan, PhD on ferroptosis targeting in RCC!

youtube.com/@AcademyofKidn…

Top Influencers in GU Ocology by LARVOL
Toni Choueiri, MD Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Petros Grivas Tom Powles Andrea Apolo, M.D. Matt Galsky Tian Zhang, MD, MHS Elizabeth Plimack MD Brian Rini, MD
oncodaily.com/43245.html

#Cancer #GUOncology #LARVOL #OncoDaily #Oncology

Part 2 of bladder sparing approaches in muscle invasive bladder cancer Michiel van der Heijden - new drugs, utDNA, ctDNA and radiotherapy could change everything. Will we need adjuvant therapy? podcasters.spotify.com/pod/show/the-u…

This one doesn’t disappoint⁩. Crushed a bit by ⁦Matt Galsky⁩ biomarker comment “if you know the future predicting the future isn’t helpful” ⁦Tom Powles⁩ ⁦⁦Brian Rini, MD⁩ podcasts.apple.com/us/podcast/the…

🎙️ #ICYMI : In the latest Uromigos episode, Brian Rini, MD and Tom Powles sat down with Tanya Dorff to discuss her work investigating #acapatamab , a #CD3 and #PSMA bispecific t-cell engaging antibody studied in advanced #ProstateCancer .

👂 Listen Here: buff.ly/4a5DqOw